Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Japanese Journal of Infectious Diseases|January 26, 2012
In vitro combination effects of aztreonam and aminoglycoside against multidrug-resistant Pseudomonas aeruginosa in JapanHideki Araoka, Masaru Baba, Kazuhiro Tateda, et al.
Scandinavian Journal of Infectious Diseases|December 17, 2009
Monobactam and aminoglycoside combination therapy against metallo-beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'Hideki Araoka, Masaru Baba, Shinsuke Takagi, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 16, 2008
Umbilical cord blood transplantation after reduced-intensity conditioning for elderly patients with hematologic diseasesNaoyuki Uchida, Atsushi Wake, Shinsuke Takagi, et al.
Blood|January 15, 2011
Successful sustained engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with severe aplastic anemiaHisashi Yamamoto, Daisuke Kato, Naoyuki Uchida, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|March 21, 2017
Potential Impact of Rapid Blood Culture Testing for Gram-Positive Bacteremia in Japan with the Verigene Gram-Positive Blood Culture TestKen Kikuchi, Mari Matsuda, Shigekazu Iguchi, et al.
Transplantation|June 17, 2011
Mycophenolate and tacrolimus for graft-versus-host disease prophylaxis for elderly after cord blood transplantation: a matched pair comparison with tacrolimus aloneNaoyuki Uchida, Atsushi Wake, Nobuaki Nakano, et al.
Blood|June 19, 2009
Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantationNaofumi Matsuno, Atsushi Wake, Naoyuki Uchida, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2016
A Novel Reduced-Toxicity Myeloablative Conditioning Regimen Using Full-Dose Busulfan, Fludarabine, and Melphalan for Single Cord Blood Transplantation Provides Durable Engraftment and Remission in Nonremission Myeloid MalignanciesHisashi Yamamoto, Naoyuki Uchida, Mitsuhiro Yuasa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 3, 2005
Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patientsHiroto Narimatsu, Tomoko Matsumura, Masahiro Kami, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 28, 2014
Anti-HLA antibodies other than against HLA-A, -B, -DRB1 adversely affect engraftment and nonrelapse mortality in HLA-mismatched single cord blood transplantation: possible implications of unrecognized donor-specific antibodiesHisashi Yamamoto, Naoyuki Uchida, Naofumi Matsuno, et al.
Pageof 7